SUBSCRIBE Subscribe to our RSS Feed

CMLHope.Com

A Worldwide Support Network For Chronic Myelogenous Leukemia

  • home
  • About
  • Contact
  • Sponsored By RealEstateZoo.Com

Archives

  • May 2012
  • March 2012
  • February 2012
  • January 2012
  • October 2011
  • September 2011
  • July 2011
  • June 2011
  • May 2011
  • April 2011
  • March 2011
  • February 2011
  • January 2011
  • December 2010
  • November 2010
  • October 2010
  • September 2010
  • August 2010
  • July 2010
  • June 2010
  • May 2010
  • April 2010
  • March 2010
  • February 2010
  • January 2010
  • December 2009
  • November 2009
  • October 2009
  • September 2009
  • August 2009
  • July 2009
  • June 2009
  • May 2009
  • April 2009
  • March 2009
  • February 2009
  • January 2009
  • December 2008
  • November 2008
  • October 2008
  • September 2008
  • August 2008
  • July 2008
  • June 2008
  • May 2008
  • April 2008
  • March 2008
  • February 2008
  • January 2008
  • December 2007
  • November 2007
  • October 2007
  • September 2007
  • August 2007
  • July 2007
  • June 2007
  • May 2007
  • April 2007
  • March 2007
  • February 2007
  • January 2007
  • December 2006
  • November 2006
  • October 2006
  • September 2006
  • August 2006
  • July 2006
  • June 2006
  • May 2006
  • April 2006
  • March 2006
  • February 2006
  • January 2006
  • December 2005
  • November 2005
  • October 2005
  • September 2005
  • August 2005
  • July 2005
  • June 2005
  • May 2005
  • April 2005
  • March 2005
  • February 2005
  • January 2005
  • December 2004
  • November 2004
  • October 2004
  • September 2004
  • August 2004
  • July 2004
  • June 2004

Recent Posts

  • E2F1?dependent pathways are involved in amonafide analogue 7?d?induced DNA damage, G2/M arrest and apoptosis in p53?deficient K562 cells
  • Medical conditions and risk of adult myeloid leukemia
  • Hematopoietic Interferon Regulatory Factor 8-Deficiency Accelerates Atherosclerosis in Mice.
  • BCR-JAK2 fusion as a result of a translocation (9;22)(p24;q11.2) in a patient with CML-like myeloproliferative disease
  • A novel five-way translocation t(7;11;9;22;9)(q22;q13;q34;q11.2;q34) involving Ph chromosome in a patient of chronic myeloid leukemia: a case report
  • Reduced intensity conditioning is superior to nonmyeloablative conditioning for older chronic myelogenous leukemia patients undergoing hematopoietic cell transplant during the tyrosine kinase inhibitor era
  • Gastric Antral Vascular Ectasia in a Patient with GIST after Treatment with Imatinib: Case Report and Literature Review
  • Spinophilin: a new tumor suppressor at 17q21.
  • Metastatic basal cell carcinoma in the era of hedgehog signaling pathway inhibitors
  • Genetic testing behavior and reporting patterns in electronic medical records for physicians trained in a primary care specialty or subspecialty.
  • Altered Microenvironmental Regulation of Leukemic and Normal Stem Cells in Chronic Myelogenous Leukemia
  • Long?term outcome following imatinib therapy for chronic myelogenous leukemia, with assessment of dosage and blood levels: the JALSG CML202 study
  • Somatic mutations in the HLA genes of patients with hematological malignancy
  • Leukapheresis in management hyperleucocytosis induced complications in two pediatric patients with chronic myelogenous leukemia
  • 2??Chloro?4??aminoflavone Derivatives Selectively Targeting Hepatocarcinoma Cells: Convenient Synthetic Process, G2/M Cell Cycle Arrest and Apoptosis Triggers

 

February 2008
M T W T F S S
« Jan   Mar »
 123
45678910
11121314151617
18192021222324
25262728293031

Meta

  • Log in
  • Entries RSS
  • Comments RSS
  • WordPress.org

Medical Articles 2/7

Posted by rob on February 7, 2008 under Uncategorized | Be the First to Comment

[Cytotoxicity of allogenetic natural killer cells against CD34(+) acute myelogenous leukemia cells.]

Information is temporarily unavailable.
Targeting the Epidermal Growth Factor Receptor in High-Grade Astrocytomas.
Information is temporarily unavailable.
Expression of BCR-ABL1 oncogene relative to ABL1 gene changes overtime in chronic myeloid leukemia.
Information is temporarily unavailable.
Effects
of the mean daily doses of imatinib during the first year on survival
of patients with chronic myeloid leukemia in Japan: a study of the
Hokkaido Hematology Study Group.
Information is temporarily unavailable.
Characterization of cancer stem cells in chronic myeloid leukaemia.
Information is temporarily unavailable.

Synthetic
small interfering RNAs reduce bcr-abl gene expression in leukaemic
cells of de novo Philadelphia(+) acute myeloid leukaemia.

Add A Comment

You must be logged in to post a comment.

home top

Site Information

© 2012 CMLHope.Com
Ministry Free Theme
by eGrace Creative.

Pages

  • Home
  • About
  • Contact
  • Sponsored By RealEstateZoo.Com

Blogroll

    Contributors

    • MedWorm Query: +chronic +myelogenous +leukemia
    • pubmed: myelogenous